Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this Cagrillintide USA manufacturer week. Experts are predicting strong results driven by the strong demand of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential